Back |
home / stock / reph / reph message board
Subject | By | Source | When |
---|---|---|---|
Help me understand.... | lmbarns | investorshub | 06/08/2015 1:41:38 PM |
$REPH recent news/filings | stocktrademan | investorshub | 05/20/2015 4:28:59 PM |
Clinical trials reports next month? | johnstockmaster | investorshub | 05/18/2015 4:58:33 PM |
Second leg begins to $ 20 | johnstockmaster | investorshub | 05/13/2015 5:13:11 PM |
No worries the company is in much better | johnstockmaster | investorshub | 05/06/2015 11:48:13 AM |
REPH churning and burning... Too much negativity surrounding | protagonist12 | investorshub | 05/01/2015 9:31:22 PM |
Churning in this range to move past 20$ soon | johnstockmaster | investorshub | 04/26/2015 9:42:34 AM |
I bought this on a simulation account and | letj21 | investorshub | 04/13/2015 2:00:13 PM |
I think FDA guys are better expert to | johnstockmaster | investorshub | 04/10/2015 12:38:54 PM |
Dex-In trial in limbo, reduction of patient enrollment | protagonist12 | investorshub | 04/09/2015 5:34:56 PM |
Here is the link http://finance.yahoo.com/news/recro-pharma-announces-going-pha | johnstockmaster | investorshub | 04/09/2015 11:46:06 AM |
Thanks for the heads up. Could you post | Ado Trade | investorshub | 04/09/2015 11:43:17 AM |
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...